Hinge Health HNGE Estimates

NYSE HNGE
$92.45 +1.63 (+1.79%)
At close: Sep 4, 2026 · 4:00 PM EDT
Analyst Estimates

Hinge Health, Inc. Revenue Estimates

Periods 24
Next Period Q3 26
Consensus 235.24 M

Analysts expect Hinge Health, Inc. to report revenue of 235.24 M for Q3 26, against a range of 219.79 M to 250.70 M. The most recent reported quarter, Q2 26, came in at 212.82 M, a 11.1% beat against the 191.55 M consensus.

Metric Q1 25Q2 25Q3 25Q4 25Q1 26Q2 26Q3 26Q4 26Q1 27Q2 27Q3 27Q4 27Q1 28Q2 28Q3 28Q4 28Q1 29Q2 29Q3 29Q4 29Q1 30Q2 30Q3 30Q4 30
Reported (Actual) 123.83 M139.10 M154.21 M170.73 M182.31 M212.82 M--------
High Estimate -136.08 M151.40 M164.94 M170.93 M209.67 M250.70 M256.42 M246.19 M299.81 M324.83 M353.17 M318.47 M365.79 M
Low Estimate -122.84 M141.80 M135.77 M151.48 M173.42 M219.79 M230.64 M215.42 M250.26 M289.38 M297.08 M297.47 M306.36 M
Consensus Estimate -129.46 M146.60 M150.36 M161.20 M191.55 M235.24 M243.53 M230.80 M275.03 M307.11 M325.13 M307.97 M336.07 M
Analyst Estimates

Hinge Health, Inc. Earnings Per Share (EPS) Estimates

Periods 24
Next Period Q3 26
Consensus 0.63

Analysts expect Hinge Health, Inc. to report earnings per share of 0.63 for Q3 26, against a range of 0.57 to 0.69. The most recent reported quarter, Q2 26, came in at 0.59, a 1.7% beat against the 0.58 consensus.

Metric Q1 25Q2 25Q3 25Q4 25Q1 26Q2 26Q3 26Q4 26Q1 27Q2 27Q3 27Q4 27Q1 28Q2 28Q3 28Q4 28Q1 29Q2 29Q3 29Q4 29Q1 30Q2 30Q3 30Q4 30
Reported (Actual) 0.210.350.420.490.450.59--------
High Estimate -0.100.240.460.410.610.690.790.680.820.981.010.941.05
Low Estimate -0.100.200.420.370.550.570.650.640.760.800.950.880.97
Consensus Estimate -0.100.220.440.390.580.630.720.660.790.890.980.911.01